Girishchandra B. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Girishchandra B. Patel has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
C. G. Choquet
3 shared publicationsG. D. Sprott
2 shared publicationsG. Dennis Sprott
Institute for Biological Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario, K1A 0R6, Canada
2 shared publications- G. Dennis Sprott
Immunochemistry, Institute for Biological Sciences, National Research Council, 100 Sussex Drive, Ottawa, Ont., Canada K1A 0R6
2 shared publications J. C. Richards
National Research Council of Canada
2 shared publicationsLise Deschatelets
Institute for Biological Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario, K1A 0R6, Canada
2 shared publications
Latest Publications
- 1 January 2002
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 12 (4) , 353-372
SAFETY OF ARCHAEOSOME ADJUVANTS EVALUATED IN A MOUSE MODEL*
Archaeosomes, liposomes prepared from the polar ether lipids extracted from Archaea, demonstrate great potential as immunomodulating carriers of soluble antigens, promoting humoral and cell mediate...
- 1 January 2002
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 12 (4) , 353-372
SAFETY OF ARCHAEOSOME ADJUVANTS EVALUATED IN A MOUSE MODEL*
Archaeosomes, liposomes prepared from the polar ether lipids extracted from Archaea, demonstrate great potential as immunomodulating carriers of soluble antigens, promoting humoral and cell mediate...
- 1 January 2000
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 194 (1) , 39-49
In vitro assessment of archaeosome stability for developing oral delivery systems
- 1 January 2000
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 194 (1) , 39-49
In vitro assessment of archaeosome stability for developing oral delivery systems
- 1 January 1999
- Published by Taylor & Francis in Critical Reviews in Biotechnology
- Vol. 19 (4) , 317-357
Archaeobacterial Ether Lipid Liposomes (Archaeosomes) as Novel Vaccine and Drug Delivery Systems
Liposomes are artificial, spherical, closed vesicles consisting of one or more lipid bilayer(s). Liposomes made from ester phospholipids have been studied extensively over the last 3 decades as artificial membrane models. Considerable interest has been generated for applications of liposomes in medicine, including their use as diagnostic reagents, as carrier vehicles in vaccine formulations, or as delivery systems for drugs, genes, or cancer imaging agents. The objective of this article is to review the properties and potential applications of novel liposomes made from the membrane lipids of Archaeobacteria (Archaea). These lipids are unique and distinct from those encountered in Eukarya and Bacteria. Polar glycerolipids make up the bulk of the membrane lipids, with the remaining neutral lipids being primarily squalenes and other hydrocarbons. The polar lipids consist of regularly branched, and usually fully saturated, phytanyl chains of 20, 25, or 40 carbon length, with the 20 and 40 being most common. The phytanyl chains are attached via ether bonds to the sn-2,3 carbons of the glycerol backbone(s). It has been shown only recently that total polar lipids of archaeobacteria, and purified lipid fractions therefrom, can form liposomes. We refer to liposomes made with any lipid composition that includes ether lipids characteristic of Archaeobacteria as archaeosomes to distinguish them from vesicles made from the conventional lipids obtained from eukaryotic or eubacterial sources or their synthetic analogs. In general, archaeosomes demonstrate relatively higher stabilities to oxidative stress, high temperature, alkaline pH, action of phospholipases, bile salts, and serum proteins. Some archaeosome formulations can be sterilized by autoclaving, without problems such as fusion or aggregation of the vesicles. The uptake of archaeosomes by phagocytic cells can be up to 50-fold greater than that of conventional liposome formulations. Studies in mice have indicated that systemic administration of several test antigens entrapped within certain archaeosome compositions give humoral immune responses that are comparable to those obtained with the potent but toxic Freund's adjuvant. Archaeosome compositions can be selected to give a prolonged, sustained immune response, and the generation of a memory response. Tissue distribution studies of archaeosomes administered via various systemic and peroral routes indicate potential for targeting to specific organs. All in vitro and in vivo studies performed to date indicate that archaeosomes are safe and do not invoke any noticeable toxicity in mice. The stability, tissue distribution profiles, and adjuvant activity of archaeosome formulations indicate that they may offer a superior alternative to the use of conventional liposomes, at least for some biotechnology applications.
- 1 January 1999
- Published by Taylor & Francis in Critical Reviews in Biotechnology
- Vol. 19 (4) , 317-357
Archaeobacterial Ether Lipid Liposomes (Archaeosomes) as Novel Vaccine and Drug Delivery Systems
Liposomes are artificial, spherical, closed vesicles consisting of one or more lipid bilayer(s). Liposomes made from ester phospholipids have been studied extensively over the last 3 decades as artificial membrane models. Considerable interest has been generated for applications of liposomes in medicine, including their use as diagnostic reagents, as carrier vehicles in vaccine formulations, or as delivery systems for drugs, genes, or cancer imaging agents. The objective of this article is to review the properties and potential applications of novel liposomes made from the membrane lipids of Archaeobacteria (Archaea). These lipids are unique and distinct from those encountered in Eukarya and Bacteria. Polar glycerolipids make up the bulk of the membrane lipids, with the remaining neutral lipids being primarily squalenes and other hydrocarbons. The polar lipids consist of regularly branched, and usually fully saturated, phytanyl chains of 20, 25, or 40 carbon length, with the 20 and 40 being most common. The phytanyl chains are attached via ether bonds to the sn-2,3 carbons of the glycerol backbone(s). It has been shown only recently that total polar lipids of archaeobacteria, and purified lipid fractions therefrom, can form liposomes. We refer to liposomes made with any lipid composition that includes ether lipids characteristic of Archaeobacteria as archaeosomes to distinguish them from vesicles made from the conventional lipids obtained from eukaryotic or eubacterial sources or their synthetic analogs. In general, archaeosomes demonstrate relatively higher stabilities to oxidative stress, high temperature, alkaline pH, action of phospholipases, bile salts, and serum proteins. Some archaeosome formulations can be sterilized by autoclaving, without problems such as fusion or aggregation of the vesicles. The uptake of archaeosomes by phagocytic cells can be up to 50-fold greater than that of conventional liposome formulations. Studies in mice have indicated that systemic administration of several test antigens entrapped within certain archaeosome compositions give humoral immune responses that are comparable to those obtained with the potent but toxic Freund's adjuvant. Archaeosome compositions can be selected to give a prolonged, sustained immune response, and the generation of a memory response. Tissue distribution studies of archaeosomes administered via various systemic and peroral routes indicate potential for targeting to specific organs. All in vitro and in vivo studies performed to date indicate that archaeosomes are safe and do not invoke any noticeable toxicity in mice. The stability, tissue distribution profiles, and adjuvant activity of archaeosome formulations indicate that they may offer a superior alternative to the use of conventional liposomes, at least for some biotechnology applications.
- 1 December 1994
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 42 (2-3) , 375-384
Stability of pressure-extruded liposomes madefrom archaeobacterial ether lipids
- 1 December 1994
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 42 (2-3) , 375-384
Stability of pressure-extruded liposomes madefrom archaeobacterial ether lipids
- 1 October 1994
- Published by Canadian Science Publishing in Canadian Journal of Microbiology
- Vol. 40 (10) , 837-843
The ether lipids of Methanosarcina mazei and other Methanosarcina species, compared by fast atom bombardment mass spectrometry
The total lipids of Methanosarcina mazei accounted for 4.0% of the cell dry mass, and 90% of these were polar lipids. Nearly all of the polar fraction consisted of diether (2,3-di-O-phytanyl-sn-glycerol) and 3-hydroxydiether analogs of phosphatidylglycerol, phosphatidylinositol, phosphatidylserine, and phosphatidylethanolamine. Several highly fluorescent trace components in the lipid extracts were purified and partially characterized by mass spectrometry. Fast atom bombardment mass spectrometry of total lipid extracts provided data to establish a close relationship among the polar lipids present in Methanosarcina mazei, Methanosarcina thermophila, Methanosarcina acetivorans, Methanosarcina barkeri Fusaro, and Methanosarcina barkeri MS.Key words: diether lipids, hydroxydiether lipids, fast atom bombardment mass spectrometry, Methanosarcina, archaeobacteria.Peer reviewed: NoNRC publication: Ye
- 1 October 1994
- Published by Canadian Science Publishing in Canadian Journal of Microbiology
- Vol. 40 (10) , 837-843
The ether lipids of Methanosarcina mazei and other Methanosarcina species, compared by fast atom bombardment mass spectrometry
The total lipids of Methanosarcina mazei accounted for 4.0% of the cell dry mass, and 90% of these were polar lipids. Nearly all of the polar fraction consisted of diether (2,3-di-O-phytanyl-sn-glycerol) and 3-hydroxydiether analogs of phosphatidylglycerol, phosphatidylinositol, phosphatidylserine, and phosphatidylethanolamine. Several highly fluorescent trace components in the lipid extracts were purified and partially characterized by mass spectrometry. Fast atom bombardment mass spectrometry of total lipid extracts provided data to establish a close relationship among the polar lipids present in Methanosarcina mazei, Methanosarcina thermophila, Methanosarcina acetivorans, Methanosarcina barkeri Fusaro, and Methanosarcina barkeri MS.Key words: diether lipids, hydroxydiether lipids, fast atom bombardment mass spectrometry, Methanosarcina, archaeobacteria.Peer reviewed: NoNRC publication: Ye
- 1 June 1994
- Published by Springer Nature in Archives of Microbiology
- Vol. 161 (6) , 481-488
Ribose biosynthesis in methanogenic bacteria
- 1 June 1994
- Published by Springer Nature in Archives of Microbiology
- Vol. 161 (6) , 481-488
Ribose biosynthesis in methanogenic bacteria
- 1 June 1994
- Published by Springer Nature in Archives of Microbiology
- Vol. 161 (6) , 471-480
Purine and pyrimidine biosynthesis in methanogenic bacteria
- 1 June 1994
- Published by Springer Nature in Archives of Microbiology
- Vol. 161 (6) , 471-480
Purine and pyrimidine biosynthesis in methanogenic bacteria